DVA vs. FMS, SHC, PGNY, PODD, INCY, RDY, EXAS, SWAV, CRL, and UHS
Should you be buying DaVita stock or one of its competitors? The main competitors of DaVita include Fresenius Medical Care (FMS), Sotera Health (SHC), Progyny (PGNY), Insulet (PODD), Incyte (INCY), Dr. Reddy's Laboratories (RDY), Exact Sciences (EXAS), Shockwave Medical (SWAV), Charles River Laboratories International (CRL), and Universal Health Services (UHS). These companies are all part of the "medical" sector.
DaVita (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and community ranking.
DaVita has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.
DaVita has higher earnings, but lower revenue than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.
DaVita has a net margin of 5.70% compared to Fresenius Medical Care's net margin of 2.56%. DaVita's return on equity of 64.42% beat Fresenius Medical Care's return on equity.
DaVita presently has a consensus target price of $118.50, indicating a potential downside of 11.24%. Fresenius Medical Care has a consensus target price of $24.00, indicating a potential upside of 19.40%. Given Fresenius Medical Care's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than DaVita.
DaVita received 88 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.81% of users gave DaVita an outperform vote while only 53.94% of users gave Fresenius Medical Care an outperform vote.
90.1% of DaVita shares are owned by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are owned by institutional investors. 1.4% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, DaVita had 7 more articles in the media than Fresenius Medical Care. MarketBeat recorded 11 mentions for DaVita and 4 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.75 beat DaVita's score of 0.72 indicating that Fresenius Medical Care is being referred to more favorably in the news media.
Summary
DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.
Get DaVita News Delivered to You Automatically
Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
